IDO1 and depressive symptom measurement: The latter are associated with the onset of depression and with interferon (IFN)-α-induced major depression, since immunotherapy of chronic hepatitis C patients with IFN-α is associated with activation of T cells, IDO activity and TRYCATs formation, as well as increased serum levels of IL-6 and IL-840,49.